Skip to main
STAA

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 0%
Hold 71%
Sell 0%
Strong Sell 0%

Bulls say

Staar Surgical is expected to experience a rebound in sales, specifically in China, due to a recovery in the refractive surgery market, growth in the phakic IOL segment, and the company's dominant market share in this sector. However, there are risks such as macroeconomic factors and competition from local Chinese manufacturers that could affect the company's future growth. Despite uncertainties, the overall outlook is positive as the company is showing progress in China and has a strong product portfolio.

Bears say

Staar Surgical is facing challenges in its key foreign market and leadership changes, which may affect its stable revenue. Regulatory approval and competition are potential risks, and the stock may be undervalued, but market sentiment and liquidity and operational issues could lead to compression. A slow-growth outlook and structural challenges may limit potential for valuation improvement.

STAAR Surgical (STAA) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 71% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Buy based on their latest research and market trends.

According to 7 analysts, STAAR Surgical (STAA) has a Buy consensus rating as of Apr 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.